Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 18 | 2018 | 185 | 4.130 |
Why?
|
| Herniorrhaphy | 7 | 2016 | 34 | 2.810 |
Why?
|
| Postoperative Complications | 16 | 2018 | 837 | 2.680 |
Why?
|
| Cholecystectomy, Laparoscopic | 5 | 2018 | 20 | 1.920 |
Why?
|
| Quality Improvement | 4 | 2014 | 128 | 1.630 |
Why?
|
| Colectomy | 4 | 2016 | 20 | 1.490 |
Why?
|
| General Surgery | 7 | 2015 | 52 | 1.360 |
Why?
|
| Hernia, Ventral | 3 | 2016 | 20 | 1.350 |
Why?
|
| Surgical Mesh | 3 | 2014 | 24 | 1.260 |
Why?
|
| Hernia, Inguinal | 3 | 2016 | 19 | 1.060 |
Why?
|
| Hernia, Hiatal | 4 | 2014 | 13 | 1.060 |
Why?
|
| Middle Aged | 29 | 2018 | 8134 | 1.030 |
Why?
|
| Male | 37 | 2018 | 12743 | 1.010 |
Why?
|
| Female | 37 | 2018 | 13239 | 0.990 |
Why?
|
| Gastrectomy | 2 | 2016 | 28 | 0.970 |
Why?
|
| Treatment Outcome | 20 | 2016 | 3093 | 0.970 |
Why?
|
| Carcinoma | 2 | 2016 | 68 | 0.970 |
Why?
|
| Stomach Neoplasms | 2 | 2016 | 32 | 0.960 |
Why?
|
| Smoking | 2 | 2016 | 168 | 0.940 |
Why?
|
| Adult | 25 | 2018 | 7168 | 0.910 |
Why?
|
| Humans | 42 | 2018 | 23541 | 0.820 |
Why?
|
| Retrospective Studies | 20 | 2018 | 3122 | 0.710 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 56 | 0.690 |
Why?
|
| Educational Measurement | 3 | 2015 | 58 | 0.690 |
Why?
|
| Internship and Residency | 4 | 2015 | 204 | 0.650 |
Why?
|
| Databases, Factual | 6 | 2016 | 316 | 0.640 |
Why?
|
| Pneumonia | 2 | 2016 | 69 | 0.610 |
Why?
|
| Aged | 17 | 2018 | 7572 | 0.590 |
Why?
|
| Logistic Models | 5 | 2016 | 357 | 0.560 |
Why?
|
| Cholecystectomy | 2 | 2018 | 10 | 0.560 |
Why?
|
| Fundoplication | 3 | 2013 | 22 | 0.550 |
Why?
|
| Splenic Neoplasms | 1 | 2016 | 3 | 0.510 |
Why?
|
| Splenectomy | 1 | 2016 | 6 | 0.510 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 2016 | 3 | 0.510 |
Why?
|
| Duodenostomy | 1 | 2016 | 3 | 0.510 |
Why?
|
| Jejunostomy | 1 | 2016 | 8 | 0.510 |
Why?
|
| Cadherins | 1 | 2016 | 30 | 0.510 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.500 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.500 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 36 | 0.500 |
Why?
|
| Barrett Esophagus | 1 | 2015 | 16 | 0.490 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 25 | 0.490 |
Why?
|
| Certification | 1 | 2015 | 24 | 0.480 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 10 | 0.480 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 78 | 0.460 |
Why?
|
| United States | 8 | 2016 | 1837 | 0.460 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 6 | 0.460 |
Why?
|
| Gastroscopy | 1 | 2015 | 9 | 0.460 |
Why?
|
| Gastrostomy | 1 | 2015 | 9 | 0.460 |
Why?
|
| Appendectomy | 1 | 2014 | 13 | 0.460 |
Why?
|
| Appendicitis | 1 | 2014 | 15 | 0.450 |
Why?
|
| Mutation | 1 | 2016 | 330 | 0.450 |
Why?
|
| Follow-Up Studies | 7 | 2015 | 1492 | 0.450 |
Why?
|
| Survival Rate | 5 | 2015 | 323 | 0.450 |
Why?
|
| Patient Safety | 1 | 2015 | 35 | 0.450 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 98 | 0.450 |
Why?
|
| Colon, Sigmoid | 1 | 2014 | 11 | 0.440 |
Why?
|
| Scrotum | 1 | 2014 | 12 | 0.440 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2015 | 65 | 0.430 |
Why?
|
| Credentialing | 1 | 2014 | 5 | 0.430 |
Why?
|
| Gallstones | 1 | 2014 | 6 | 0.430 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.430 |
Why?
|
| Intestine, Small | 1 | 2014 | 31 | 0.430 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 32 | 0.420 |
Why?
|
| Gastroplasty | 4 | 2014 | 27 | 0.420 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 3 | 0.420 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 138 | 0.410 |
Why?
|
| Abdominal Wall | 1 | 2013 | 6 | 0.400 |
Why?
|
| Clinical Competence | 3 | 2015 | 202 | 0.400 |
Why?
|
| Sepsis | 1 | 2014 | 112 | 0.390 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 271 | 0.390 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 70 | 0.390 |
Why?
|
| Risk Factors | 7 | 2016 | 1997 | 0.380 |
Why?
|
| Physicians | 1 | 2014 | 108 | 0.380 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 18 | 0.370 |
Why?
|
| Operative Time | 5 | 2018 | 82 | 0.370 |
Why?
|
| Esophagus | 1 | 2012 | 57 | 0.360 |
Why?
|
| Heart Transplantation | 3 | 2015 | 29 | 0.330 |
Why?
|
| Length of Stay | 4 | 2018 | 305 | 0.310 |
Why?
|
| Obesity, Morbid | 3 | 2014 | 98 | 0.280 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 34 | 0.250 |
Why?
|
| Graft Rejection | 3 | 2015 | 61 | 0.250 |
Why?
|
| Clinical Clerkship | 3 | 2015 | 30 | 0.250 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 3767 | 0.220 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 79 | 0.220 |
Why?
|
| Reoperation | 4 | 2016 | 767 | 0.210 |
Why?
|
| Comorbidity | 2 | 2016 | 431 | 0.210 |
Why?
|
| Recurrence | 2 | 2014 | 276 | 0.200 |
Why?
|
| Students, Medical | 2 | 2013 | 53 | 0.200 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 1045 | 0.190 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 443 | 0.160 |
Why?
|
| Cholecystitis, Acute | 1 | 2018 | 2 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2015 | 245 | 0.140 |
Why?
|
| Weight Loss | 3 | 2014 | 122 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 64 | 0.140 |
Why?
|
| Lymph Nodes | 1 | 2018 | 72 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 648 | 0.130 |
Why?
|
| Time Factors | 3 | 2015 | 1293 | 0.130 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Angina Pectoris | 1 | 2016 | 16 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2015 | 1465 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2018 | 1532 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2016 | 49 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 27 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 43 | 0.120 |
Why?
|
| Cholangiography | 1 | 2015 | 7 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 297 | 0.120 |
Why?
|
| Hernia, Umbilical | 1 | 2015 | 3 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 110 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 78 | 0.120 |
Why?
|
| Writing | 1 | 2015 | 16 | 0.120 |
Why?
|
| Confidence Intervals | 1 | 2015 | 76 | 0.120 |
Why?
|
| Hypertension | 1 | 2016 | 163 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2015 | 42 | 0.120 |
Why?
|
| Sex Factors | 1 | 2016 | 393 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 17 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2015 | 30 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 26 | 0.110 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 16 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 51 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 819 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2015 | 229 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2014 | 18 | 0.110 |
Why?
|
| Lymphoma | 1 | 2014 | 36 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 112 | 0.110 |
Why?
|
| Myocardium | 1 | 2015 | 100 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 193 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 140 | 0.110 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 4 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2015 | 61 | 0.110 |
Why?
|
| Primary Graft Dysfunction | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hemobilia | 1 | 2014 | 1 | 0.110 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mirizzi Syndrome | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 2 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2014 | 2 | 0.110 |
Why?
|
| Ileus | 1 | 2014 | 3 | 0.110 |
Why?
|
| Urinary Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Biliary Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Intestinal Fistula | 1 | 2014 | 4 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2015 | 133 | 0.110 |
Why?
|
| Graft Survival | 1 | 2014 | 84 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2014 | 7 | 0.110 |
Why?
|
| Illinois | 1 | 2014 | 222 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2014 | 58 | 0.110 |
Why?
|
| Wound Healing | 1 | 2014 | 119 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 63 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 26 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 27 | 0.110 |
Why?
|
| Animals, Laboratory | 1 | 2013 | 3 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 358 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 293 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2014 | 59 | 0.100 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 4 | 0.100 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2013 | 10 | 0.100 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 37 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2015 | 555 | 0.100 |
Why?
|
| Education, Medical | 1 | 2013 | 44 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 40 | 0.100 |
Why?
|
| Radiography | 1 | 2014 | 555 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 88 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2013 | 505 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2018 | 379 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 605 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 27 | 0.080 |
Why?
|
| Actinomycetales | 1 | 2004 | 1 | 0.060 |
Why?
|
| Erythromycin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2004 | 4 | 0.060 |
Why?
|
| Young Adult | 2 | 2018 | 1745 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 18 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 53 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2018 | 209 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2018 | 247 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 317 | 0.030 |
Why?
|
| Job Application | 1 | 2015 | 6 | 0.030 |
Why?
|
| Los Angeles | 1 | 2015 | 10 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 56 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 172 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 168 | 0.030 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2014 | 1 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2014 | 7 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 17 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 113 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 100 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 53 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 68 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 324 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 230 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2013 | 114 | 0.030 |
Why?
|
| Anxiety | 1 | 2013 | 142 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2012 | 114 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 749 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2013 | 207 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 403 | 0.020 |
Why?
|
| History, 18th Century | 1 | 2009 | 5 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 132 | 0.020 |
Why?
|
| Animals | 1 | 2013 | 3293 | 0.020 |
Why?
|
| Glucosyltransferases | 1 | 2004 | 1 | 0.010 |
Why?
|
| Saccharopolyspora | 1 | 2004 | 1 | 0.010 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2004 | 1 | 0.010 |
Why?
|
| Fatty Acid Synthases | 1 | 2004 | 1 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 2 | 0.010 |
Why?
|
| Thiolester Hydrolases | 1 | 2004 | 3 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 7 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2004 | 3 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2004 | 9 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 27 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 39 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 37 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 48 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 33 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 186 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 89 | 0.010 |
Why?
|